New OTC Nexium approved

Share this article:

Pfizer's consumer portfolio now includes a 24-hour version of over-the-counter Nexium. The company announced Friday that the FDA greenlighted the no-prescription heartburn medication.

The company is also pursuing an OTC version of its former prescription blockbuster cholesterol medication Lipitor.

Pfizer acquired worldwide marketing rights to the non-Rx version of AZ's blockbuster proton-pump inhibitor in 2012. Deal terms called for a $250-million upfront payment.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.